Serum procalcitonin value is useful for predicting severity of Kawasaki disease

Pediatric Infectious Disease Journal

Volumn 31, Issue 5, 2012, Pages 523-525

  Yoshikawa, Hideki ^a   Nomura, Yuichi ^a   Masuda, Kiminori ^b   Koriya, Chihaya ^a   Arata, Michiko ^a   Hazeki, Daisuke ^a   Yanagimoto, Kosuke ^a   Ueno, Kentaro ^a   Eguchi, Taisuke ^a   Kawano, Yoshifumi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b Kagoshima City Hospital   (Japan)

Author keywords

Coronary artery abnormality; Intravenous immunoglobulin; Kawasaki disease; Nonresponder; Procalcitonin

Indexed keywords

IMMUNOGLOBULIN; PROCALCITONIN;

ARTICLE; CHILD; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SINGLE DRUG DOSE; TREATMENT RESPONSE;

CALCITONIN; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEIN PRECURSORS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 84860244036     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3182463879     Document Type: Article

References (10)

1. Roweley AH, Shulman ST. Kawasaki disease. In: Kliegman RM, Behrman RE, Jenson HB, et al, eds. Textbook of Pediatrics. 18th ed. Philadelphia, PA: WB Saunders; 2007:1036-1042.
2. JCS Joint Working Group. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2008). Circ J. 2010; 74:1989-2020.
3. Wallace CA, French JW, Kahn SJ, et al. Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatrics. 2000;105:E78.
4. Pafflin A, Schleicher E. Inflammation markers in point-of-care testing (POCT). Anal Bioanal Chem. 2009;393:1473-1480.
5. Aikawa N, Fujishima S, Endo S, et al. Multicenter prospective study of procalcitonin as an indicator of sepsis. J Infect Chemother. 2005;11:152-159.
6. Endo S, Aikawa N, Fujishima S, et al. Usefulness of procalcitonin serum level for the discrimination of severe sepsis from sepsis: a multicenter prospective study. J Infect Chemother. 2008;14:244-249.
7. Okada Y, Minakami H, Tomomasa T, et al. Serum procalcitonin concentration in patients with Kawasaki disease. J Infect. 2004;48:199-205.
8. Catalano-Pons C, Andre MC, Chalumeau M, et al. Lack of value of procalcitonin for prediction of coronary aneurysms in Kawasaki disease. Pediatr Infect Dis J. 2007;26:179-180.
9. Kurotobi S, Nagai T, Kawakami N, et al. Coronary diameter in normal infants, children and patients with Kawasaki disease. Pediatr Int. 2002;44:1-4.
10. Kobayashi T, Inoue Y, Takeuchi K, et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation. 2006;113:2606-2612.